3-(5-substituted benzyl)amino-2-phenylpiperidines as substance p antagonists
CA 2193468 C · Owner: Pfizer Inc. · Inventors: Wakabayashi, Hiroaki; Shishido, Yuji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a compound of the formula: (see fig. I), (I), and its pharmaceutically acceptable salts wherein, R1 is C1-C6 alkyl, C3-C6 cycloalkyl halo C1-C6 alkyl or terahydropyranyl, having one or more substituents selected from cyano 1,3-thiazolanyl, COOR2, COR2, OCOR2, CONR3R4 NR3R4, NR5COR3 and CCR6, wherein R2 is hydrogen or C1-C4 alkyl, R3 and R4 are independently hydrogen C1-C4 alkyl or C3-C6 cycloalkyl, R5 is C1-C4 alkyl or C3-C6 cycloalkyl and R6 is hydrogen halo, cyano, C1-C6 alkyl, COOH, COO(C1-C4 alkyl) or phenyl; X is C1-C6 alkoxy or halo C1-C6 alkoxy; and Ar is phenyl optionally substituted with halo. These compounds are useful in the treatment of allergic disorders …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 1996 and granted April 24, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 19, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.